☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Jazz' Xywav Receives the US FDA's Approval for the Treatment of Idiopathic Hypersomnia
August 13, 2021
Aprea Reports the FDA's Hold on Clinical Trials for the Treatment Lymphoid Malignancy
August 13, 2021
Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology
August 13, 2021
Ipsen Reports the Withdrawal of NDA for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva
August 13, 2021
Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil
August 13, 2021
Junshi and Coherus's Toripalimab Receive the US FDA's Breakthrough Therapy Designation as 1L Treatment of Nasopharyngeal Carcinoma
August 13, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions